Science and innovation are the lifeblood of our company. But we’re
doing more than developing medicines that perform well in the
lab—we’re elevating the current standard of care to bring greater
benefits to our patients.
482 million
patients living with conditions that our pipeline aims to treat, from cancer and Alzheimer’s disease to chronic immune-mediated conditions
THERAPEUTIC FOCUS AREAS
Researching Areas of Unmet Medical Need
We’re constantly finding new ways to address patients’ most serious health issues. We concentrate our efforts on a core set of therapeutic areas—ones where we’ve proven our expertise, and where we feel we can have an even greater impact on disease and how it is managed.
Drug Development Process
From discovery to clinical trials to regulatory approval, learn more about the journey to bring a new therapy to patients.

Bringing Better Solutions to Patients
By investing in groundbreaking technologies and platforms, our goal is to drive innovation within our pipeline and deliver better solutions to patients.

Devoted to New Discoveries
Our scientists are advancing a pipeline of specialty medicines with a
focus on cancer, immune-mediated conditions, neurodegenerative
diseases and more.

A Portfolio of Medicines
We aim to develop innovative therapies for health conditions where there is a significant need. Our medicines are approved in individual countries for different uses around the globe.

CLINICAL TRIALS
Advancing Medical Knowledge
We have investigational compounds in development within each of our therapeutic areas. A critical component of medicinal product development is clinical research, which involves conducting clinical trials to evaluate the safety and efficacy of potential new therapies.

Make New Medicines Possible
Whether you or a relative are interested in participating in a trial, our Clinical Trials and Me website can help address your questions. It offers information about clinical trials and lists our current clinical trials. You’ll also learn how to prepare for one and what to expect during and after a clinical trial.